| Product Code: ETC7646941 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Brugada Syndrome Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Brugada Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Brugada Syndrome Market - Industry Life Cycle |
3.4 Israel Brugada Syndrome Market - Porter's Five Forces |
3.5 Israel Brugada Syndrome Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Israel Brugada Syndrome Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Israel Brugada Syndrome Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Israel Brugada Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of Brugada syndrome in Israel |
4.2.2 Advancements in genetic testing and diagnostic technologies |
4.2.3 Supportive government policies and healthcare infrastructure in Israel for rare diseases |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for Brugada syndrome |
4.3.2 High cost of genetic testing and treatment for Brugada syndrome in Israel |
5 Israel Brugada Syndrome Market Trends |
6 Israel Brugada Syndrome Market, By Types |
6.1 Israel Brugada Syndrome Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Israel Brugada Syndrome Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Israel Brugada Syndrome Market Revenues & Volume, By ElectrocardiogramElectrocardiogram, 2021- 2031F |
6.1.4 Israel Brugada Syndrome Market Revenues & Volume, By Electrophysiology (EP) Test, 2021- 2031F |
6.1.5 Israel Brugada Syndrome Market Revenues & Volume, By Genetic Testing, 2021- 2031F |
6.2 Israel Brugada Syndrome Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Israel Brugada Syndrome Market Revenues & Volume, By Implantable Cardioverter-Defibrillator, 2021- 2031F |
6.2.3 Israel Brugada Syndrome Market Revenues & Volume, By Drug Therapy, 2021- 2031F |
6.3 Israel Brugada Syndrome Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Israel Brugada Syndrome Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.3 Israel Brugada Syndrome Market Revenues & Volume, By Surgical Centers, 2021- 2031F |
6.3.4 Israel Brugada Syndrome Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
7 Israel Brugada Syndrome Market Import-Export Trade Statistics |
7.1 Israel Brugada Syndrome Market Export to Major Countries |
7.2 Israel Brugada Syndrome Market Imports from Major Countries |
8 Israel Brugada Syndrome Market Key Performance Indicators |
8.1 Number of Brugada syndrome cases diagnosed annually in Israel |
8.2 Adoption rate of genetic testing for Brugada syndrome in Israel |
8.3 Investment in research and development of new treatments for Brugada syndrome in Israel |
9 Israel Brugada Syndrome Market - Opportunity Assessment |
9.1 Israel Brugada Syndrome Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Israel Brugada Syndrome Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Israel Brugada Syndrome Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Israel Brugada Syndrome Market - Competitive Landscape |
10.1 Israel Brugada Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Israel Brugada Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here